Genetic modification of PUFA biosynthesis and CHD
PUFA生物合成与CHD的基因改造
基本信息
- 批准号:7220061
- 负责人:
- 金额:$ 65.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-08 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdipose tissueAffectArachidonic AcidsBinding ProteinsBiochemicalBiological MarkersBlood ClotBlood coagulationCase-Control StudiesConditionCoronary heart diseaseCosta RicaCytochrome P450DNADataDevelopmentDietDietary Fatty AcidDocosahexaenoic AcidsEicosanoidsEicosapentaenoic AcidEnzymesEssential Fatty AcidsEvaluationFatty Acid DesaturasesFatty AcidsFeedbackGene Expression RegulationGenesGeneticGenetic TranscriptionGenetic VariationGoalsHaplotypesIndividualInflammationIntakeLinkLinolenic AcidsMeasurementMembraneModificationMutationMyocardial InfarctionNumbersOmega-3 Fatty AcidsPPAR alphaPathway interactionsPolyunsaturated Fatty AcidsPopulationPreventionRangeRegulationRegulatory ElementRelative (related person)Research PersonnelResolutionRiskRoleSamplingSignal TransductionSterolsSurvivorsTestingTrans Fatty AcidsVariantalpha-Linolenic Acidbaseblood pressure regulationdesaturaseeicosanoid metabolismexperiencefatty acid biosynthesisgene interactionsaturated fattranscription factor
项目摘要
DESCRIPTION (provided by applicant): Polyunsaturated fatty acids (PUFA) exert vital functions on membrane structure, cell signaling, and regulation of gene expression. PUFA are the precursors of several different eicosanoids, which have multiple roles in inflammation, regulation of blood pressure, and blood clotting, among many other functions. Through these functions, PUFA are undoubtedly linked to the prevention of development of coronary heart disease (CHD). Linoleic (n-6) and alpha-linolenic acid (n-3) are essential fatty acids (FA) that can be converted into long- chain PUFA through elongation, desaturation, and strong feedback regulated by transcription factors, sterol desaturases enzymes involved in this biosynthetic pathway are regulated by transcription factors, sterol regulatory element-binding protein-1c (SREBP-1c) and peroxisome proliferators-activated receptor-alpha (PPAR-alpha). We hypothesize that mutations in these genes affect FA biosynthesis and risk of CHD. Our overall objective is to assess individual variability in the effect of dietary PUFA on Ml, by examining genes involved in their biosynthetic pathway. We will study 2,150 case survivors of Ml and 2,150 population-based controls from out ongoing study. Specific hypothesis will examine the genetic mechanisms that link intake of FA [1) n-3 FAs: alpha-linolenic acid, eicosapentaenoic acid (EPA), and docsahexaenoic acid, (DMA); 2) n-6 FAs: linoleic acid, and arachidonic acid, and 3) trans FA] to risk of Ml. The proposed genes include: fatty acid desaturase (FADS)2 (delta6-desaturase), FADS1 (delta5-desaturase), and FADS3, ELOVL-1,2,3,4,5,6,7 (7 elongase genes), PPAR-alpha, and SREBP-1c. Further hypothesis will be tested with other genes involved in the synthesis of eicosanoids from arachidonic acid and EPA: cycloxygenase(COX)-2, S-lypoxygenase(LOX), and cytochrome P450 2J2 (CYP2J2). FAs in adipose tissue will be used as biomarkers of intake. Biochemical measurements, dietary data, and general information are available for this population. The proposed study offers and unusual opportunity to expand our understanding of how genetic and environmental conditions can influence CHD. The diet of the population offers a wide range in variation of all the major types of FAs, particularly with low ranges of saturated fat and n-3 FAs represented. This strengthens evaluation of risk, and application to current dietary goals. The large number of SNPs proposed for final analysis will add to the resolution and power to identify the genes that underlie CHD.
描述(由申请人提供):多不饱和脂肪酸(PUFA)对膜结构,细胞信号传导和基因表达的调节发挥重要作用。 PUFA是几种不同的类花生酸酯的前体,在炎症,血压调节和血液凝结中具有多个作用,以及许多其他功能。通过这些功能,PUFA无疑与预防冠心病(CHD)的发展有关。 Linoleic (n-6) and alpha-linolenic acid (n-3) are essential fatty acids (FA) that can be converted into long- chain PUFA through elongation, desaturation, and strong feedback regulated by transcription factors, sterol desaturases enzymes involved in this biosynthetic pathway are regulated by transcription factors, sterol regulatory element-binding protein-1c (SREBP-1c) and peroxisome扩散剂激活的受体-Alpha(PPAR-Alpha)。我们假设这些基因的突变会影响FA生物合成和CHD风险。我们的总体目标是通过检查与其生物合成途径有关的基因来评估饮食PUFA对ML的影响。我们将研究2,150名ML的病例幸存者和来自OUT持续研究的2,150个基于人群的对照。具体假设将检查连接FA摄入的遗传机制[1)N-3 FAS:α-烯醇酸,eicosapentaenoic(EPA)和Docsahecahexaenoic,(DMA); 2)N-6 FAS:亚油酸和花生四烯酸,以及3)反式FA]。所提出的基因包括:脂肪酸去饱和酶(FADS)2(Delta6-决定酶),FADS1(delta5-脱发酶)和FADS3,Elovl-1,2,3,4,5,6,7(7个元负酶基因),PPAR-ALPHA和SREBPP-1C。进一步的假设将与涉及的其他基因一起测试来自花生四烯酸和EPA的eicosanoids:环氧酶(COX)-2,S-糖酶(LOX)和细胞色素P450 2J2(CYP2J2)。脂肪组织中的FAS将用作摄入量的生物标志物。生化测量,饮食数据和一般信息可用于该人群。拟议中的研究提供了不寻常的机会,以扩大我们对遗传和环境状况如何影响冠心病的理解。人群的饮食在所有主要类型的FAS的变化方面具有广泛的范围,尤其是代表饱和脂肪和N-3 FA的低范围。这加强了对风险的评估,并应用了当前饮食目标。提出的最终分析的大量SNP将增加分辨率和功率,以识别基因冠心基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANA B BAYLIN其他文献
ANA B BAYLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANA B BAYLIN', 18)}}的其他基金
Genetic Modification of Triggers of Acute Myocardial Infarction
急性心肌梗死触发因素的基因改造
- 批准号:
7989323 - 财政年份:2010
- 资助金额:
$ 65.09万 - 项目类别:
Genetic Modification of Triggers of Acute Myocardial Infarction
急性心肌梗死触发因素的基因改造
- 批准号:
8122216 - 财政年份:2010
- 资助金额:
$ 65.09万 - 项目类别:
Genetic modification of PUFA biosynthesis and CHD
PUFA生物合成与CHD的基因改造
- 批准号:
7103946 - 财政年份:2006
- 资助金额:
$ 65.09万 - 项目类别:
相似国自然基金
糖尿病肾病外泌体miRNAs介导内脏脂肪组织巨噬细胞-系膜细胞crosstalk影响肾脏自噬功能及丹酚酸B的作用
- 批准号:81974531
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
围产期奶牛高NEFA血症对脂肪组织脂代谢和分泌机能的影响
- 批准号:31572581
- 批准年份:2015
- 资助金额:64.0 万元
- 项目类别:面上项目
4-HNE诱导的脂肪功能紊乱对酒精性脂肪肝发病作用的影响及机制研究
- 批准号:81470845
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
麦没食子儿茶素没食子酸酯对肥胖大鼠脂肪组织中TNF-α表达的影响及其机制的研究
- 批准号:81000327
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
多不饱和脂肪酸对草鱼脂肪细胞发育的影响及其分子机理的研究
- 批准号:30771667
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 65.09万 - 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 65.09万 - 项目类别:
Role of SIK3 in PKA/mTORC1 regulation of adipose browning
SIK3 在 PKA/mTORC1 调节脂肪褐变中的作用
- 批准号:
10736962 - 财政年份:2023
- 资助金额:
$ 65.09万 - 项目类别:
Regulation of cellular senescence and metabolic health by dietary protein
膳食蛋白质调节细胞衰老和代谢健康
- 批准号:
10678729 - 财政年份:2023
- 资助金额:
$ 65.09万 - 项目类别:
Regulation of tissue-resident helper type 2 T cells by fatty acid transport protein 4 (FATP4)
脂肪酸转运蛋白 4 (FATP4) 对组织驻留辅助型 2 T 细胞的调节
- 批准号:
10677098 - 财政年份:2023
- 资助金额:
$ 65.09万 - 项目类别: